X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Kidney International Supplements

期刊標題檢索 KIDNEY INT SUPP 最新評論: This journal took off with a bang, scoring a direct 90 points, which ... (2025-06-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Kidney International Supplements]您好,您是該頁面的第 18657 位訪客。

期刊簡介
期刊名稱Kidney International Supplements Kidney International Supplements
LetPub Score
8.8
50 ratings
Rate

Reputation
10.0

Influence
8.1

Speed
7.0

期刊簡稱KIDNEY INT SUPPL
ISSN2157-1724
E-ISSN2157-1716
h-index24
CiteScore
CiteScoreSJRSNIPCiteScore Rank
46.2010.78817.647
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Nephrology
Q11 / 91

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Kidney International Supplements is published on behalf of the International Society of Nephrology (ISN) and comes complimentary as part of a subscription to Kidney International. Kidney International Supplements is a peer-reviewed journal whose focus is sponsored, topical content of interest to the nephrology community.
官方網站http://www.kisupplements.org/
在線稿件提交https://mc.manuscriptcentral.com/kir
開放訪問No
出版商Elsevier Inc.
主題領域UROLOGY & NEPHROLOGY
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數9每年文章數趨勢
黃金OA百分比0.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
UROLOGY & NEPHROLOGYSCIEQ11/133
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2157-1724%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Kidney International Supplements】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 1154.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 181.80
    LANCETH-index: 700

    CiteScore: 87.60
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 96.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 114.50
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 113.30
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 103.80
    MMWR Recommendations and ReportsH-index: 0

    CiteScore: 129.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 84.70
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 30.80
    學科內最受檢索的期刊 頁面查看次數
    PHARMACEUTICAL BIOLOGY23305309
    Frontiers in Pharmacology6572842
    Oncology Letters1615963
    BIOMATERIALS1577116
    Cancer Medicine1073945
    Oncogenesis1007097
    JOURNAL OF ETHNOPHARMACOLOGY723924
    Archives of Medical Science718814
    MEDICINE703457
    Frontiers in Oncology595075
  •  

    Kidney International Supplements Kidney International Supplements
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Kidney International Supplements] 的評論撰寫評論
作者: 宋游


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-20 00:52:54 評論於
This journal took off with a bang, scoring a direct 90 points, which is incredible.
(0) 讚! | 宋游

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:03:10 評論於
The method of relative quantification in qPCR is described as the ΔΔCT method, which involves first normalizing with internal reference genes and then calculating the differences between the sample and control groups
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:51:06 評論於
Calculate the average value Mean using Average(), standard deviation SD using STDEV.S(), and standard error SEM using STDEV.S()/COUNT()^0.5
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 20:17:45 評論於
How to handle qPCR results?
(0) 讚! | 陶宜三岁啦

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 15:59:12 評論於
How to calculate margin of error?
(0) 讚! | 北国博达

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Kidney International Supplements] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*